Member Info for Rocket79

Last chance guys news could drop any day this week or next.

This will blow past 3p and onto 5p on sign off which is within a week... investors have not realised that yet... Gold hitting record highs. Those holding long term this wili be 34p–42p at full ramp-up with $4000 gold, using normal mid-tier miner PE multiples and project economics. This is including Saudi.

"34p–42p at full ramp-up with $4000 gold, using normal mid-tier miner PE multiples and project economics"

I agree. Exciting times

Last chance guys news could drop any day this week or next.

This will blow past 3p and onto 5p on sign off which is within a week... investors have not realised that yet... Gold hitting record highs. Those holding long term this wil be 15-20p within 2 years.

Last chance guys news could drop any day this week or next.

This will blow past 3p and onto 5p on sign off which is within a week... investors have not realised that yet... Gold hitting record highs. Those holding long term this wil be 15-20p within 2 years.

This will blow past 3p and onto 5p on sign off which is within a week... investors have not realised that yet... Gold hitting record highs. Those holding long term this wil be 15-20p within 2 years.

Pentwater has made a very strong bullish bet on Renalytix, doubling its total exposure primarily through a derivative instrument that provides a high degree of economic upside if the share price rises.

Pentwater's percentage of direct shares decreased because the total number of Renalytix shares in the market increased substantially due to the fundraise, diluting the percentage of the company represented by Pentwater's fixed number of shares.

​Crucially, the increase in their total holding (shares + financial instruments) shows a clear move by Pentwater to increase their overall economic exposure to Renalytix, despite the technical dilution of their direct share percentage.

They have same amount of shares so did not sell. They increased their holding but just diluted slightly due to placing.

The oversubscribed placing by both institutional investors, private investors and the directors bode well for the future. The directors are putting their money where their mouths are. This is a great sign of confidence. You don't often see a share both fundamentally and technically strong at an inflection point where it has formed a strong base for a coiled spring, propelling the share price upwards. My target remains at 20 p short term.

Follow the money. Institutions piling in here. This is going to rerate. Buy and hold imo.

Large trades coming in. Institutions never bought in to make a few pence on the sp. This will end day blue... Good luck all

The oversubscribed placing by both institutional investors, private investors and the directors bode well for the future. The directors are putting their money where their mouths are. This is a great sign of confidence. You don't often see a share both fundamentally and technically strong at an inflection point where it has formed a strong base for a coiled spring, propelling the share price upwards. My target remains at 20 p short term.

Yes and the Tempus AI collaboration is the biggest of them all. The CEO of a multi billion dollar company does not tweet the below for fun. DYOR

So below is one of the reasons this is a no brainer.

Now why would the CEO tweet the below?? Tempus is a multi billion dollar company... They know they can make some serous money with the collaboration with Renalytix. Takeover coming imo

Ryan FukushimaRyan Fukushima COO at Tempus AI | Cofounder of Pathos AIThe brutal truth about chronic kidney disease:

• 15 million Americans have diabetic kidney disease • 90% patients don't even know they have it

• Medicare spends $130 billion annually cleaning up the aftermathThis isn't just market opportunity. It's a silent epidemic.

[Enter Renalytix] FDA-approved test. Medicare reimbursed. Predicts kidney disease progression in diabetic patients.

But here's what stopped me in my tracks about them:

They weren't pitching their algorithm's accuracy. They were obsessing over physician workflow integration.

That's when I knew we had to work together.

Golden Cross formed on close yesterday... we are in a bullish phase. Institutions to paid millions to get in at this price. They can see the value....

Massive buys coming in... smart money moving in here for the rerate. What an opportunity

Very bullish. Fully funded for a US expansion though our collaboration with a multi billion dollar company... Buy and hold this will multibag just like Hemo and Imm

Now placings complete this puts a floor at 9.5p only way is up now. Nothing holding this back.Strong Buy

Educated buyers coming in now as the short term traders mive on. This should not have dropped. Institutions and directors just backed the company putting in millions.

This will be over 15p in the coming days if not today.